Targeted Imaging Offers Advantages Over Physiological Imaging for Evaluation of Angiogenic Therapy**Editorials published in JACC: Cardiovascular Imaging reflect the views of the authors and do not necessarily represent the views of JACC: Cardiovascular Imaging or the American College of Cardiology.

JACC: Cardiovascular Imaging

Volumn 1, Issue 4, 2008, Pages 511-514

  Sinusas, Albert J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

angiogenesis; molecular imaging; myocardial hibernation; radionuclide imaging; VEGF

Indexed keywords

AMMONIA; ANTIANGINA PECTORIS AGENT; ARGINYLGLYCYLASPARTIC ACID; CONTRAST MEDIUM; FIBROBLAST GROWTH FACTOR 2; INDIUM 111; IODINE 123; MONOCLONAL ANTIBODY; NANOPARTICLE; NITROGEN 13; OXYGEN 15; PLACEBO; PLASMID DNA; RADIOPHARMACEUTICAL AGENT; RECEPTOR BLOCKING AGENT; RP 748; RUBIDIUM 82; THALLIUM 201; TRACER; VASCULOTROPIN 165; VASCULOTROPIN C; VITRONECTIN RECEPTOR ANTAGONIST;

ANGIOGENESIS; ANGIOPLASTY; ANTIANGIOGENIC THERAPY; CLINICAL TRIAL; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; DRUG DELIVERY SYSTEM; DRUG MONITORING; EDITORIAL; GENE TRANSFER; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HUMAN; HYPOXIA; IMAGING; ISOTOPE LABELING; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVASCULARIZATION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TISSUE OXYGENATION;

ANIMALS; CAPILLARIES; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CORONARY STENOSIS; ECHOCARDIOGRAPHY; FIBROSIS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GLUCOSIDES; HUMANS; INTEGRIN ALPHAVBETA3; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; OLIGOPEPTIDES; RADIOPHARMACEUTICALS; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 48049083513     PISSN: 1936878X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcmg.2008.05.010     Document Type: Editorial

References (25)

1. Renault M.-A., and Losordo D.W. Therapeutic myocardial angiogenesis. Microvasc Res 74 (2007) 159-171
2. Fallavollita J.A., Logue M., and Canty Jr. J.M. Stability of hibernating myocardium in pigs with a chronic left anterior descending coronary artery stenosis: absence of progressive fibrosis in the setting of stable reductions in flow, function and coronary flow reserve. J Am Coll Cardiol 37 (2001) 1989-1995
3. Hughes G.C., Post M.J., Simons M., et al. Translational physiology: porcine models of human coronary artery disease: implications for preclinical trials of therapeutic angiogenesis. J Appl Physiol 94 (2003) 1689-1701
4. Johnson L., Schofield L., Donahay T., et al. Radiolabeled arginine-glycine-aspartic acid peptides to image angiogenesis in swine model of hibernating myocardium. J Am Coll Cardiol Img 1 (2008) 500-510
5. Vale P.R., Losordo D.W., Tkebuchava T., et al. Catheter-based myocardial gene transfer utilizing nonfluoroscopic electromechanical left ventricular mapping. J Am Coll Cardiol 34 (1999) 246-254
6. Vale P.R., Losordo D.W., Milliken C.E., et al. Randomized, single-blind, placebo-controlled pilot study of catheter-based myocardial gene transfer for therapeutic angiogenesis using left ventricular electromechanical mapping in patients with chronic myocardial ischemia. Circulation 103 (2001) 2138-2143
7. Losordo D., Vale P., Hendel R., et al. Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia. Circulation 105 (2002) 2012-2018
8. Kastrup J., Jorgensen E., Ruck A., et al. Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris: a randomized double-blind placebo-controlled study: the Euroinject One trial. J Am Coll Cardiol 45 (2005) 982-988
9. Rissanen T.T., and Yla-Herttuala S. Current status of cardiovascular gene therapy. Mol Ther 15 (2007) 1233-1247
10. Simons M., Bonow R.O., Chronos N.A., et al. Clinical trials in coronary angiogenesis: issues, problems, consensus: an expert panel summary. Circulation 102 (2000) E73-E86
11. Carmeliet P. Angiogenesis in health and disease. Nat Med 9 (2003) 653-660
12. Meoli D.F., Sadeghi M.M., Krassilnikova S., et al. Noninvasive imaging of myocardial angiogenesis following experimental myocardial infarction. J Clin Invest 113 (2004) 1684-1691
13. Hua J., Dobrucki L., Sadeghi M., et al. Noninvasive imaging of angiogenesis with a 99mTc-labeled peptide targeted at αvβ3 integrin after murine hindlimb ischemia. Circulation 111 (2005) 3255-3260
14. Lindsey M.L., Escobar G.P., Dobrucki L.W., et al. Matrix metalloproteinase-9 gene deletion facilitates angiogenesis after myocardial infarction. Am J Physiol Heart Circ Physiol 290 (2006) H232-H239
15. Kalinowski L., Dobrucki L.W., Meoli D.F., et al. Targeted imaging of hypoxia-induced integrin activation in myocardium early after infarction. J Appl Physiol 104 (2008) 1504-1512
16. Lee K.-H., Jung K.-H., Song S.-H., et al. Radiolabeled RGD uptake and {alpha}v integrin expression is enhanced in ischemic murine hindlimbs. J Nucl Med 46 (2005) 472-478
17. Higuchi T., Bengel F.M., Seidl S., et al. Assessment of {alpha}v{beta}3 integrin expression after myocardial infarction by positron emission tomography. Cardiovasc Res 78 (2008) 395-403
18. Ferrara N., Gerber H., and LeCouter J. The biology of VEGF and its receptors. Nat Med 9 (2003) 669-676
19. Humphries M. Integrin activation: the link between ligand binding and signal transduction. Curr Opin Cell Biol 8 (1996) 632-640
20. Sipkins D.A., Cheresh D.A., Kazemi M.R., Nevin L.M., Bednarski M.D., and Li K.C. Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging. Nat Med 4 (1998) 623-626
21. Haubner R., Wester H., Burkhart F., et al. Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics. J Nucl Med 42 (2001) 326-336
22. de Muinck E., and Pearlman J.D. Targeted magnetic resonance imaging of angiogenesis in the vascular system. In: Gropler R., Glover D., Sinusas A., et al. (Eds). Cardiovascular molecular imaging (2007), Informa Healthcare, New York, NY
23. Jacquier A., Higgins C.B., Martin A.J., et al. Injection of adeno-associated viral vector encoding vascular endothelial growth factor gene in infarcted swine myocardium: MR measurements of left ventricular function and strain. Radiology 245 (2007) 196-205
24. Saeed M., Saloner D., Martin A., et al. Adeno-associated viral vector-encoding vascular endothelial growth factor gene: effect on cardiovascular MR perfusion and infarct resorption measurements in swine. Radiology 243 (2007) 451-460
25. Rissanen T., Korpisalo P., Karvinen H., et al. High-resolution ultrasound perfusion imaging of therapeutic angiogenesis. J Am Coll Cardiol Img 1 (2008) 83-91